Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CQ211 is a potent and selective RIOK2 inhibitor with a Kd of 6.1 nM.CQ211 has shown potent proliferation inhibitory activity against various cancer cell lines in vitro.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 152.00 | |
5 mg | In stock | $ 378.00 | |
10 mg | In stock | $ 622.00 | |
25 mg | In stock | $ 1,230.00 | |
50 mg | In stock | $ 1,980.00 | |
100 mg | In stock | $ 2,500.00 |
Description | CQ211 is a potent and selective RIOK2 inhibitor with a Kd of 6.1 nM.CQ211 has shown potent proliferation inhibitory activity against various cancer cell lines in vitro. |
Targets&IC50 | RIOK2:6.1 nM(Kd) |
In vivo | CQ211 (25 mg/kg; rat) inhibits the tumor progression with tumor growth inhibition (TGI) of 30.9%.[1] |
Molecular Weight | 521.49 |
Formula | C26H22F3N7O2 |
CAS No. | 2648986-65-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 6.25 mg/mL (11.98 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CQ211 2648986-65-4 Others inhibitor inhibit